These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 16406697

  • 1. Evidence for a rapid action of levetiracetam compared to topiramate in refractory partial epilepsy.
    Specchio LM, Boero G, Specchio N, De Agazio G, De Palo A, de Tommaso M, Beghi E, La Neve A.
    Seizure; 2006 Mar; 15(2):112-6. PubMed ID: 16406697
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG, Berkovic SF, Black AB, Danta G, Hiersemenzel R, Schapel GJ, Vajda FJ.
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [Abstract] [Full Text] [Related]

  • 3. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF.
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [Abstract] [Full Text] [Related]

  • 4. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
    Kinirons P, McCarthy M, Doherty CP, Delanty N.
    Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
    [Abstract] [Full Text] [Related]

  • 5. Add-on topiramate in the treatment of refractory partial-onset epilepsy: clinical experience of outpatient epilepsy clinics from 11 general hospitals.
    Giannakodimos ST, Georgiadis G, Tsounis ST, Triantafillou N, Kimiskidis V, Giatas K, Karlovasitou A, Mitsikostas DD, Thodi E, Polychronopoulos P, Ramopoulos N, Michailidis K, Michalis N, Garganis K, Gatzonis ST, Balogiannis ST, Kazis AR, Milonas J, Van Oene JC.
    Seizure; 2005 Sep; 14(6):396-402. PubMed ID: 16019237
    [Abstract] [Full Text] [Related]

  • 6. Long-term efficacy of levetiracetam for partial seizures.
    Abou-Khalil B, Schaich L.
    Seizure; 2005 Dec; 14(8):577-85. PubMed ID: 16280250
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
    Uthman BM, Almas M, Emir B, Giordano S, Leon T.
    Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients.
    Heo K, Lee BI, Yi SD, Huh K, Kim JM, Lee SA, Shin DJ, Song HK, Lee SK, Kim JY, Lu S, Dubois C, Tonner F.
    Seizure; 2007 Jul; 16(5):402-9. PubMed ID: 17369059
    [Abstract] [Full Text] [Related]

  • 13. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE, Nordli DR, Rating D, Yang H, Schiemann-Delgado J, Duncan B, Levetiracetam N01009 Study Group.
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [Abstract] [Full Text] [Related]

  • 14. Perampanel with concomitant levetiracetam and topiramate: Post hoc analysis of adverse events related to hostility and aggression.
    Chung S, Williams B, Dobrinsky C, Patten A, Yang H, Laurenza A.
    Epilepsy Behav; 2017 Oct; 75():79-85. PubMed ID: 28830031
    [Abstract] [Full Text] [Related]

  • 15. Onset of action of levetiracetam: a RCT trial using therapeutic intensive seizure analysis (TISA).
    Stefan H, Wang-Tilz Y, Pauli E, Dennhöfer S, Genow A, Kerling F, Lorber B, Fraunberger B, Halboni P, Koebnick C, Gefeller O, Tilz C.
    Epilepsia; 2006 Mar; 47(3):516-22. PubMed ID: 16529615
    [Abstract] [Full Text] [Related]

  • 16. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP.
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of levetiracetam in clinical practice: results of the SKATE trial from Belgium and The Netherlands.
    Lambrechts DA, Sadzot B, van Paesschen W, van Leusden JA, Carpay J, Bourgeois P, Urbain E, Boon PA.
    Seizure; 2006 Sep; 15(6):434-42. PubMed ID: 16893660
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.